Immix Biopharma Appoints Chief Commercial Officer to Drive NXC-201 Launch
- Former Chimerix (CMRX, acquired by Jazz for $935 million) Senior Commercial Leader Michael Grabow led Go-To-Market Strategy and Launch...
Clinical Trial
Moleculin Announces Grant Funded Research Evaluating Annamycin for the Treatment of Pancreatic Cancer at UNC-Chapel Hill
Preclinical research to be conducted at the University of North Carolina at Chapel Hill (UNC) Annamycin will be used in...
Evotec Receives Milestone Payment from Bristol Myers Squibb Following IND Acceptance in Strategic Protein Degradation Partnership
Milestone payment reflects continued progress under strategic research collaboration addressing high-need patient populationsFDA clearance of IND application triggered a US$...
TriSalus Life Sciences to Participate in Upcoming Investor Conferences
WESTMINSTER, Colo.--(BUSINESS WIRE)--TriSalus Life Sciences® Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), an oncology company integrating novel delivery technology with...
Lapsi Health and eMurmur® Unveil AI Analytics Integration for Keikku 2.0
Partnership Delivers Cardiac Auscultation Accuracy to the World's First FDA-Cleared AI Scribe Stethoscope HOUSTON and OTTAWA, ON, Nov. 11, 2025...
Olympus Corporation Announces Newest Appointments to Help Drive Innovation and Patient Safety for Respiratory Business
Dr. Gildea and Dr. Ötvös Named Newest Members of Medical & Scientific Affairs CENTER VALLEY, Pa., Nov. 11, 2025 /PRNewswire/...
Pacific Software Inc Announces Exclusive Partnership with SpectroChip Global
DANA POINT, Calif., Nov. 11, 2025 /PRNewswire/ - Pacific Software Inc. (OTC: PFSF), today announced the closing of its transaction...
Becoming a sponsor of choice for high-performing sites, Upcoming Webinar Hosted by Xtalks
In this free webinar, understand and learn how to address the increasing demands on clinical research sites. Attendees will gain...
Dogwood Announces Enrollment of First 100 Patients in Ongoing Halneuron(R) Phase 2b Trial, Interim Sample Size Analysis on Track for December 2025
- Continued low early termination rate among the first 80 study completers suggests Halneuron® and placebotreatmenthave been well tolerated ATLANTA,...
NanoViricides Announces Pricing of $6 Million Registered Direct Offering and Concurrent Private Placement Priced at the Market Close
SHELTON, CONNECTICUT / ACCESS Newswire / November 11, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), today announced that it...
Zomedica Announces “Friday at Four” Webinar on November 21st Providing Strategic Overview & Third Quarter 2025 Business Review
November session to provide strategic context for Zomedica's product platforms featured in the previous Fourth Friday at Four Webinars ANN...
Altimmune Announces Publication of IMPACT Phase 2b Trial Data in The Lancet and Concurrent Late-Breaking Oral Presentation at AASLD The Liver Meeting® 2025
24-week data demonstrated significant MASH resolution and weight loss, and strong evidence of anti-fibrotic activity with a favorable tolerability profile...
myTomorrows Raises $29 Million to Scale and Transform Access to Innovative Therapies for Patients Worldwide
Investment by Avego will extend reach, accelerate AI innovation, and deepen industry partnerships. AMSTERDAM, Nov. 11, 2025 /PRNewswire/ -- myTomorrows,...
Mentavi Health Introduces “Mentavi Concierge” – Setting a New Standard for Responsible AI in Digital Health
Built for trust and compliance, the AI support assistant streamlines intake and routes visitors and patients to human‑led care. GRAND...
Ontada Presents Framework for Accelerating Clinical Development with Real-World External Control Arms in Phase 2 Trials at ISPOR
The novel framework is designed to help accelerate clinical development through more efficient and informative early-stage trialsBOSTON--(BUSINESS WIRE)--Ontada®, a leader...
CASI Pharmaceuticals Receives and Appeals Delisting Determination from NASDAQ
SOUTH SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / November 10, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company...
Federal Marijuana Crackdown Confirms the Future: DEA’s Obstruction of MMJ Science Exposed as Congress Moves to Re-Criminalize the $30 Billion THC Gray Market
MMJ International Holdings stands as one of a few compliant, FDA regulated blueprint for cannabis medicine as a 37 state...
TriSalus Life Sciences to Host Virtual KOL Event to Discuss the TriNav Infusion System for the Treatment of Uterine Fibroids on November 12, 2025
WESTMINSTER, Colo.--(BUSINESS WIRE)--TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), an oncology company integrating novel delivery technology with...
TriSalus Life Sciences to Host Virtual KOL Event to Discuss the TriNav Infusion System for the Treatment of Uterine Fibroids on November 12, 2025
WESTMINSTER, Colo.--(BUSINESS WIRE)--TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), an oncology company integrating novel delivery technology with...
CNS Pharmaceuticals Announces Acceptance of Three Abstracts for Poster Presentation at the Society of NueroOncology (SNO) 30th Annual Meeting
HOUSTON, TX / ACCESS Newswire / November 10, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical...